Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.

28 Apr 2011

PURE Bioscience introduces new Hard Surface disinfectant

PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate antimicrobial, today announced the launch of its proprietary new brand, PURE Hard Surface disinfectant and food contact surface sanitizer at the 2011 California State PTA Annual Convention being held April 28 - May 1 in Long Beach, California.

28 Apr 2011

Calls for improvement of hospital food by Australian Medical Association

According to the Australian Medical Association (AMA) the standards of meals must improve in public hospitals in South Australia or more patients will be discharged in a malnourished state. It says nutrition is being addressed but the overall standard of meals is not high enough. They added that for elderly patients there are simple obstacles such as hard-to-open food packaging.

28 Apr 2011

ASTRO develops new thoracic radiotherapy guideline

The American Society for Radiation Oncology has developed a guideline for the use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused by advanced lung cancer. The guideline will be published in Practical Radiation Oncology, an official journal of ASTRO.

28 Apr 2011

Nursing environment linked to improved patient outcomes

Better working conditions and better staffing of nurses can significantly improve the care of patients with serious conditions, according to the latest nurse labor study by the University of Maryland School of Nursing.

28 Apr 2011

Tsetse fly mapping distribution model may help solve sleeping sickness mystery

Since before the 1300s, people living in many parts of Africa have been dying from a disease known as sleeping sickness. Despite public health campaigns that explain ways to stop infection—primarily by killing the disease-spreading tsetse fly—successful eradication has remained out of reach. That's partly because epidemiologists can't predict where cases will emerge next.

28 Apr 2011

The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.

28 Apr 2011

American Lung Association releases 2011 annual air quality report

Today, the American Lung Association released its annual report on air quality, State of the Air 2011, which includes lists of the nation's most polluted metropolitan areas.

27 Apr 2011

Court's rejection of fast-track request raises questions, issues

The court's online order did not offer any legal reasoning, nor were dissenting opinions noted. However, Justice Elena Kagan did participate in the decision. Meanwhile, Politico Pro explores some of the key questions that will be at stake surrounding the law's "individual mandate" as the challenges now wind through through the federal appeals courts this summer.

27 Apr 2011

Northwestern Asthma-COPD Program with palliative medicine can enhance patient care

When faced with a long-term illness, patients often retreat or are left feeling hopeless, a response that can negatively impact one's prognosis and impair their quality of life. When coping measures are offered however, the opposite can hold true.

27 Apr 2011

Biologists determine molecular structure of GluN2D receptor subunit

Structural biologists at Cold Spring Harbor Laboratory in collaboration with colleagues at Emory University have determined the molecular structure of a key portion, or subunit, of a receptor type commonly expressed in brain cells.

27 Apr 2011

EPO grants patent to Microbix' VIRUSMAX vaccine enhancement technology

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent protection for the company's proprietary VIRUSMAX technology, which is designed to increase influenza vaccine yields and has demonstrated an average yield increase of at least two-fold over current vaccine production methods.

27 Apr 2011

Azithromycin holds promise for preventing BPD in Ureaplasma-infected preterm infants

A study performed by University of Kentucky researchers shows promise for the use of azithromycin in treating Ureaplasma-colonized or infected premature infants to prevent bronchopulmonary dysplasia (BPD).

27 Apr 2011

New study sheds light on evolution of 2009 pandemic influenza A(H1N1) virus in Japan

Analysis of mutations of the 2009 pandemic influenza A(H1N1) virus by researchers at the RIKEN Omics Science Center (OSC) has revealed major genetic differences between the virus in its early phase of infection in Japan and in its peak phase. While yielding valuable clues on the genetic origins of drug resistance, the findings also pave the way toward the development of new diagnostic kits for detecting and preventing the spread of global pandemic diseases.

26 Apr 2011

New angle in cause of tuberculosis discovered - scientists hopeful for new therapy

In a new study published Monday, researchers from the US have isolated the enzyme that allows tuberculosis to destroy lung tissue. This discovery could speed the search for treatments.

26 Apr 2011

Millennium submits two VELCADE sNDAs to FDA

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).

26 Apr 2011

FDA grants Cepheid marketing clearance for Xpert Flu diagnostic test

Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® Flu. The diagnostic test, which runs on Cepheid's GeneXpert® System, simultaneously detects and differentiates Influenza A, Influenza B, and the 2009 H1N1 influenza virus in about one hour.

26 Apr 2011

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that several of its defensin-mimetic antibiotic compounds have shown antimicrobial efficacy in an animal model against the bacteria that causes anthrax.

26 Apr 2011

Infants with bronchopulmonary dysplasia can benefit from azithromycin therapy

A study performed by University of Kentucky researchers shows promise for the use of azithromycin in treating Ureaplasma-colonized or infected premature infants to prevent bronchopulmonary dysplasia.

26 Apr 2011

Scientists identify key enzyme that destroys lung tissue in TB

Scientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis, they report today in the Journal of Clinical Investigation. Drugs that inhibit this enzyme are already available, meaning that the finding could lead quickly to new treatments.

26 Apr 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

PURE Bioscience introduces new Hard Surface disinfectant

Calls for improvement of hospital food by Australian Medical Association

ASTRO develops new thoracic radiotherapy guideline

Nursing environment linked to improved patient outcomes

Tsetse fly mapping distribution model may help solve sleeping sickness mystery

The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

American Lung Association releases 2011 annual air quality report

Court's rejection of fast-track request raises questions, issues

Northwestern Asthma-COPD Program with palliative medicine can enhance patient care

Biologists determine molecular structure of GluN2D receptor subunit

EPO grants patent to Microbix' VIRUSMAX vaccine enhancement technology

Azithromycin holds promise for preventing BPD in Ureaplasma-infected preterm infants

New study sheds light on evolution of 2009 pandemic influenza A(H1N1) virus in Japan

New angle in cause of tuberculosis discovered - scientists hopeful for new therapy

Millennium submits two VELCADE sNDAs to FDA

FDA grants Cepheid marketing clearance for Xpert Flu diagnostic test

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

Infants with bronchopulmonary dysplasia can benefit from azithromycin therapy

Scientists identify key enzyme that destroys lung tissue in TB

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in